14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ALLK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Allakos Inc. stock price ended at $1.01 on Thursday, after losing 0.98%.
(Updated on Apr 25, 2024)

Sell candidate since Mar 12, 2024 Loss -24.06% PDF

The Allakos Inc. stock price fell by -0.98% on the last day (Thursday, 25th Apr 2024) from $1.02 to $1.01. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 6.13% from a day low at $0.98 to a day high of $1.04. The price has fallen in 7 of the last 10 days and is down by -16.53% for this period. Volume has increased on the last day by 215 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 376 thousand shares were bought and sold for approximately $379.42 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.00 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -16.50% during the next 3 months and, with a 90% probability hold a price between $0.83 and $1.22 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ALLK Signals & Forecast

There are few to no technical positive signals at the moment. The Allakos Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.05 and $1.22. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -38.41%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Allakos Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Allakos Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0601 between high and low, or 6.13%. For the last week, the stock has had daily average volatility of 6.09%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALLK) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Allakos Inc. to open at $1.01, and during the day (based on 14 day Average True Range), to move between $0.93 and $1.09, which gives a possible trading interval of +/-$0.0843 (+/-8.35%) up or down from last closing price. If Allakos Inc. takes out the full calculated possible swing range there will be an estimated 16.69% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.22, some $0.210 (20.79%) from the current price of $1.01, our system finds the risk reward not very attractive.

Is Allakos Inc. stock A Buy?

Allakos Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.710 Strong Sell Candidate Unchanged

Predicted Opening Price for Allakos Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$1.01 ( 0.0033%) $1.01

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALLK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.07 5.95 %
R2 1.05 3.67 %
R1 1.03 2.27 %
Current price: 1.01
Support S1 0.99 -2.28 %
S2 0.97 -3.68 %
S3 0.95 -5.95 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.25 23.76 %
R2 1.23 21.78 %
R1 1.22 20.79 %
Current price 1.01
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Allakos Inc. Stock and on which exchange is it traded?
The symbol for Allakos Inc. is ALLK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Allakos Inc. Stock?
Allakos Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Allakos Inc. Stock?
Allakos Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Allakos Inc. Stock.

What's the current price of Allakos Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an Allakos Inc. (ALLK) share was $1.01.

What is the 52-week high and low for Allakos Inc. Stock?
The 52-week high for Allakos Inc. Stock is $5.64 and the 52-week low is $0.98.

What is the market capitalization of Allakos Inc. Stock?
As of the Apr 25, 2024, the market capitalization of Allakos Inc. is 88.753M.

When is the next earnings date for Allakos Inc.?
The upcoming earnings date for Allakos Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Allakos Inc.

Allakos. Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical... ALLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT